Christopher I. Amos

52.6k total citations · 2 hit papers
544 papers, 18.6k citations indexed

About

Christopher I. Amos is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Christopher I. Amos has authored 544 papers receiving a total of 18.6k indexed citations (citations by other indexed papers that have themselves been cited), including 229 papers in Molecular Biology, 205 papers in Genetics and 121 papers in Oncology. Recurrent topics in Christopher I. Amos's work include Genetic Associations and Epidemiology (122 papers), Genetic factors in colorectal cancer (72 papers) and Genetic Mapping and Diversity in Plants and Animals (54 papers). Christopher I. Amos is often cited by papers focused on Genetic Associations and Epidemiology (122 papers), Genetic factors in colorectal cancer (72 papers) and Genetic Mapping and Diversity in Plants and Animals (54 papers). Christopher I. Amos collaborates with scholars based in United States, Canada and United Kingdom. Christopher I. Amos's co-authors include Margaret R. Spitz, Xifeng Wu, Qingyi Wei, Sanjay Shete, Ivan P. Gorlov, Xiangjun Gu, M R Spitz, Qiong Dong, Mariza de Andrade and Marsha L. Frazier and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Christopher I. Amos

524 papers receiving 18.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1

2008 879 citations Christopher I. Amos, Xifeng Wu et al. profile →
Meta-analyses of colorectal cancer risk factors

2013 571 citations Christopher I. Amos et al. profile →

Peers

Countries citing papers authored by Christopher I. Amos

Since Specialization

Citations

This map shows the geographic impact of Christopher I. Amos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher I. Amos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher I. Amos more than expected).

Fields of papers citing papers by Christopher I. Amos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher I. Amos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher I. Amos. The network helps show where Christopher I. Amos may publish in the future.

Co-authorship network of co-authors of Christopher I. Amos

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher I. Amos. A scholar is included among the top collaborators of Christopher I. Amos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher I. Amos. Christopher I. Amos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two-Sample Mendelian Randomization Analysis of Associations Between Periodontal Disease and Risk of Cancer 2021 ·JNCI Cancer Spectrum ·Laura Corlin, Mengyuan Ruan, Konstantinos K. Tsilidis, Emmanouil Bouras, Yau‐Hua Yu, Rachael Z. Stolzenberg‐Solomon, Alison P. Klein, Harvey A. Risch, Christopher I. Amos, Lori C. Sakoda, Pavel Vodička, (unknown), James D. Beck, Elizabeth A. Platz, Dominique S. Michaud	15
2	Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors 2021 ·Cancer Research ·Hong Wei, Ang Li, Yanhong Liu, Xiangjun Xiao, David C. Christiani, Rayjean J. Hung, James McKay, John K. Field, Christopher I. Amos, Chao Cheng	15
3	Population simulations of COVID-19 outbreaks provide tools for risk assessment and continuity planning 2021 ·JAMIA Open ·Bo Peng, Rowland W. Pettit, Christopher I. Amos	3
4	Physical Activity Does Not Lower the Risk of Lung Cancer 2020 ·Cancer Research ·Sebastian‐Edgar Baumeister, Michael F. Leitzmann, Martin Bahls, Christa Meisinger, Christopher I. Amos, Rayjean J. Hung, Alexander Teumer, Hansjörg Baurecht	12
5	A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck 2020 ·Cancer Research ·Sanjay Shete, Hongliang Liu, Jian Wang, Robert Yu, Erich M. Sturgis, Guojun Li, Kristina R. Dahlstrom, Zhensheng Liu, Christopher I. Amos, Qingyi Wei	37
6	Cross-Cancer Pleiotropic Associations with Lung Cancer Risk in African Americans 2019 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Yuki Bradford, Christopher I. Amos, William J. Blot, Stephen J. Chanock, Curtis C. Harris, Ann G. Schwartz, Margaret R. Spitz, John K. Wiencke, Margaret Wrensch, Xifeng Wu, Melinda C. Aldrich	8
7	Transcriptomic Differences between Primary Colorectal Adenocarcinomas and Distant Metastases Reveal Metastatic Colorectal Cancer Subtypes 2019 ·Cancer Research ·(unknown), Stephanie L. Schmit, (unknown), Christopher I. Amos, H. Robert Frost	50
8	A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis 2018 ·Molecular Cancer Research ·Yanding Zhao, Evelien Schaafsma, (unknown), Eva Hernando, Nancy E. Thomas, Ronglai Shen, Mary Jo Turk, Marianne Berwick, Christopher I. Amos, Chao Cheng	22
9	A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic Variations 2016 ·Cancer Epidemiology Biomarkers & Prevention ·David C. Qian, Younghun Han, Jinyoung Byun, (unknown), Rayjean J. Hung, John McLaughlin, Maria Teresa Landi, Daniela Seminara, Christopher I. Amos	22
10	PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer 2016 ·Clinical Cancer Research ·David C. Qian, Xiangjun Xiao, Jinyoung Byun, Arief A. Suriawinata, (unknown), Christopher I. Amos, Richard J. Barth	17
11	Underestimation of Risk of a BRCA1 or BRCA2 Mutation in Women With High-Grade Serous Ovarian Cancer by BRCAPRO: A Multi-Institution Study 2014 ·Journal of Clinical Oncology ·Molly S. Daniels, (unknown), (unknown), Diana L. Urbauer, (unknown), Amanda Brandt, Christopher I. Amos, Adam H. Buchanan, David G. Mutch, Karen H. Lu	22
12	Polymorphisms in MicroRNAs Are Associated with Survival in Non–Small Cell Lung Cancer 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Yang Zhao, Qingyi Wei, (unknown), Feng Chen, Zhibin Hu, Rebecca S. Heist, Li Su, Christopher I. Amos, Hongbing Shen, David C. Christiani	20
13	Gene Variants in Angiogenesis and Lymphangiogenesis and Cutaneous Melanoma Progression 2013 ·Cancer Epidemiology Biomarkers & Prevention ·Jong Y. Park, Ernest K. Amankwah, Gabriella M. Anic, Hui‐Yi Lin, (unknown), (unknown), (unknown), Melissa H. Madden, (unknown), Suroosh S. Marzban, Shenying Fang, (unknown), Jeffrey E. Lee, Qingyi Wei, Christopher I. Amos, Jane L. Messina, Vernon K. Sondak, Thomas A. Sellers, Kathleen M. Egan	17
14	Multistage Analysis of Variants in the Inflammation Pathway and Lung Cancer Risk in Smokers 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Margaret R. Spitz, Ivan P. Gorlov, Qiong Dong, Xifeng Wu, Wei Chen, David W. Chang, Carol J. Etzel, Neil E. Caporaso, Yang Zhao, David C. Christiani, Paul Brennan, Demetrius Albanes, Jianxin Shi, Michael J. Thun, Maria Teresa Landi, Christopher I. Amos	25
15	Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans 2012 ·Cancer Epidemiology Biomarkers & Prevention ·Kyle M. Walsh, Ivan P. Gorlov, Helen M. Hansen, Xifeng Wu, Margaret R. Spitz, Huifeng Zhang, (unknown), Angela S. Wenzlaff, Jennette D. Sison, Chongjuan Wei, Stacy M. Lloyd, Wei Chen, Marsha L. Frazier, Michael F. Seldin, Laura J. Bierut, Paige M. Bracci, Margaret Wrensch, Ann G. Schwartz, John K. Wiencke, Christopher I. Amos	27
16	A Genome-Wide Association Study Identifies a Locus on Chromosome 14q21 as a Predictor of Leukocyte Telomere Length and as a Marker of Susceptibility for Bladder Cancer 2011 ·Cancer Prevention Research ·Jian Gu, Meng Chen, Sanjay Shete, Christopher I. Amos, Ashish M. Kamat, Yuanqing Ye, Jie Lin, Colin P. Dinney, Xifeng Wu	53
17	Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Pengyuan Liu, Haris G. Vikis, Yan Lü, Yian Wang, Ann G. Schwartz, Susan M. Pinney, Ping Yang, Mariza de Andrade, Adi F. Gazdar, Colette Gaba, Diptasri Mandal, Juwon Lee, Elena Kupert, Daniela Seminara, John D. Minna, Joan E. Bailey‐Wilson, Christopher I. Amos, Marshall W. Anderson, Ming You	26
18	Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study 2009 ·Cancer Research ·Peter Broderick, Yufei Wang, Jayaram Vijayakrishnan, Athena Matakidou, Margaret R. Spitz, Timothy Eisen, Christopher I. Amos, Richard S. Houlston	155
19	High Prevalence of Preinvasive Lesions Adjacent to BRCA1/2-Associated Breast Cancers 2009 ·Cancer Prevention Research ·Banu Arun, Kristen J. Vogel, Adriana López, Mike Hernández, (unknown), Kristine Broglio, Christopher I. Amos, Funda Meric‐Bernstam, Henry M. Kuerer, Gabriel N. Hortobágyi, Constance T. Albarracin	21
20	Seizure 6-Like ( SEZ6L ) Gene and Risk for Lung Cancer 2007 ·Cancer Research ·Ivan P. Gorlov, (unknown), Triantafillos Liloglou, Jonathan P. Myles, Melanie Barbara Boettger, Adrian Cassidy, Luc Girard, John D. Minna, (unknown), Stephen W. Duffy, Margaret R. Spitz, Karl Haeußinger, Stefan Kammerer, Charles R. Cantor, R Dierkesmann, John K. Field, Christopher I. Amos	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact